14 may 2024
Vitafoods Europe 2024
Cerbios-Pharma SA

Cerbios-Pharma SA

Exhibitor at Vitafoods Europe 2024 stand S238

About us

With over 40 years in the pharmaceutical industry, Cerbios Pharma is a privately held company with headquarter in Lugano, Switzerland, specializing in the development and manufacture of :

-  Probiotic based finished formulations (targeting different therapeutic areas), based on its own proprietary probiotic strain SF68
 - Chemical and biological APIs: (Methyl-folate; 5 MTHF: biologically active form of folic acid)

Microbiota (gut bacteria) impacts on health of several body districts, gut, skin, metabolism, immune system, CNS. Probiotics can balance microbiota with positive effects on some pathologies.

Cerbios developed finished formulations targeting different syndromes, supporting efficacy with scientific evidences and trials.
 
FINISHED FORMULATIONS BASED ON PROBIOTICS:

  • SF68 SKINActive: management and prevention of acne and seborrheic dermatitis. Clinically Proven 
  • SF68 IMMUNO: boosting immune system. Scientifically backed. 
  • SF68 SLIPIDÒ: to manage and prevent dyslipidemias, obesity and metabolic syndrome. Clinically Proven 
  • SF68 IBSoft: for management and prevention of IBS symptoms. Clinically Proven 
  • NEWFLORA: for treatment of diarrhea, traveler’s diarrhea, infective diarrhea. Drug product: with e-CTD and CPP from Switzerland
API:
  • (Methyl-folate/ 5 MTHF): biologically active form of folic acid. 

Specs about this supplier

Sales markets Asia; Central/South America; Eastern Europe; Middle East; Western Europe
Affiliated categories: Food Supplements / Nutraceuticals |Pharmaceutical Ingredients |Postbiotics More

Products featured at Vitafoods Europe 2024

Cerbios-Pharma SA

Event information

Vitafoods Europe 2024

14 - 16 May 2024 - Geneva, Switzerland Visit us at stand S238